Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.005
+0.005 (0.53%)
Mar 14, 2025, 11:29 AM EDT - Market open

Inozyme Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
6517826342161482
Upgrade
Market Cap Growth
-32.37%-32.37%520.31%-73.72%-66.54%-
Upgrade
Enterprise Value
-293105-9240323
Upgrade
Last Close Price
1.002.774.261.056.8220.64
Upgrade
PB Ratio
1.113.081.870.361.483.05
Upgrade
P/TBV Ratio
3.083.081.870.361.483.05
Upgrade
Debt / Equity Ratio
0.810.810.330.060.03-
Upgrade
Quick Ratio
3.353.3512.878.709.6214.83
Upgrade
Current Ratio
3.563.5613.368.939.9215.14
Upgrade
Return on Equity (ROE)
-102.90%-102.90%-54.98%-58.91%-42.36%-55.64%
Upgrade
Return on Assets (ROA)
-40.13%-40.13%-27.81%-32.67%-24.17%-32.81%
Upgrade
Return on Capital (ROIC)
-44.57%-44.57%-30.28%-36.10%-26.15%-35.16%
Upgrade
Earnings Yield
-158.86%-57.33%-27.05%-158.11%-35.08%-11.70%
Upgrade
FCF Yield
-143.21%-51.68%-26.98%-137.15%-30.08%-7.57%
Upgrade
Buyback Yield / Dilution
-21.17%-21.17%-37.27%-60.30%-113.46%-832.81%
Upgrade
Total Shareholder Return
-21.17%-21.17%-37.27%-60.30%-113.46%-832.81%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.